Updated Data in Multiple Myeloma and First Data in non-Hodgkin’s Lymphoma from the Ongoing Phase 1/2 Trial of Cemsidomide Presented at ASH 2024
Dec 8, 2024 5:00 PM EST
Event Details
You are now leaving c4therapeutics.com
You are about to leave C4 Therapeutics, Inc. (C4T)'s website. This link will take you to an independent website that C4T does not control and to which our Privacy Policy does not apply. C4T is not responsible for the privacy practices or content of any third party websites. We encourage you to read the applicable privacy policies and terms of use of such websites prior to using them.
You are now leaving c4therapeutics.com
You are about to leave C4 Therapeutics, Inc. (C4T)'s website. This link will take you to an independent website that C4T does not control and to which our Privacy Policy does not apply. C4T is not responsible for the privacy practices or content of any third party websites. We encourage you to read the applicable privacy policies and terms of use of such websites prior to using them.